Wen, S., J. Zeng, L. Zhong, J. Ye, and X. Lai. “The Efficacy and Adverse Effects of Nivolumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma: Nivolumab and Lenvatinib in the Treatment of HCC”. Cellular and Molecular Biology, vol. 68, no. 11, Nov. 2022, pp. 53-57, doi:10.14715/cmb/2022.68.11.10.